Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure.

NCT02681991 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Daewon Pharmaceutical Co., Ltd.